Risk Adapted SABR(SABR) in Stage I NSCLC And Lung Metastases
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 56
Summary
- Conditions
- Carcinoma Non-small-cell Lung
- Neoplasm Metastasis
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
The intervention (dose and fractions) depends on topographical parameters: lung disease (primary, peripheral nodes or mediastinal nodes), distance to chest wall, tumour size and distance to main bronchus.
The intervention (dose and fractions) depends on topographical parameters: lung disease (primary, peripheral nodes or mediastinal nodes), distance to chest wall, tumour size and distance to main bronchus.
Tracking Information
- NCT #
- NCT01823003
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Arturo Navarro-Martin, md Institut Català d'Oncologia L'Hospitalet
Get Well Soon